Lexaria Bioscience Corp LEXX

Buzz on the Bullboards: Bombardier, world woes, a smart fridge, and top shelf weed

[Jonathon Brown]

A highlight of the week was Bombardier (TSX:BBD), which reported impressive growth in its Q3 2024 results. read article.

[lscfa]

CBD with Lexaria tech outperforms weight loss drug Rybelsus in mice. Hope it's the same in human studies.

[PressRelease]

(TheNewswire)- DehydraTECH-liraglutide and a select DehydraTECH-CBD formulation were the top performing groups in the Study outperforming the Rybelsus® control group in both body weight-loss, by 11.53% and 10.65% respectively, and in blood sugar, by 11.13% and 3.35% respectively.- DehydraTECH...read article.

[PressRelease]

DehydraTECH-liraglutide and a select DehydraTECH-CBD formulation were the top performing groups in the Study outperforming the Rybelsus® control group in both body weight-loss, by 11.53% and 10.65% respectively, and in blood sugar, by 11.13% and 3.35% respectively.DehydraTECH-semaglutide...read article.

[PressRelease]

(TheNewswire)World’s First-Ever Study Tracking Biodistribution of DehydraTECH GLP-1 MoleculesKelowna, British Columbia – November 14, 2024 – TheNewswire – Lexaria Bioscience Corp. (Nasdaq: LEXX, LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, announces it has...read article.

[PressRelease]

(TheNewswire)DehydraTECH clinical test article manufacturing has been completedKelowna, British Columbia – TheNewswire - November 13, 2024 – Lexaria Bioscience Corp. (Nasdaq: LEXX, LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, announces it has received lead...read article.

[PressRelease]

(TheNewswire)DehydraTECH™ for GLP-1 being optimized for global pharmaceutical useKelowna, British Columbia – TheNewswire - November 7, 2024 – Lexaria Bioscience Corp. (Nasdaq: LEXX & LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms provides the following glucagon...read article.

[PressRelease]

(TheNewswire)DehydraTECH-liraglutide and select DehydraTECH-CBD formulations were the top performing blood sugar groupsKelowna, British Columbia – October 24, 2024 – TheNewswire – Lexaria Bioscience Corp. (Nasdaq: LEXX & LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery...read article.

[PressRelease]

(TheNewswire)DehydraTECH-liraglutide and select DehydraTECH-CBD formulations were the top performing weight loss groupsAccelerated rates of weight loss were experienced during the final 4 weeks of the study in all DehydraTECH groupsKelowna, British Columbia – October 22, 2024 – TheNewswire...read article.

[PressRelease]

(TheNewswire)Kelowna, British Columbia – October 16, 2024 – TheNewswire – Lexaria Bioscience Corp. (Nasdaq: LEXX; LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, today announced that it has closed its previously announced registered direct offering priced at...read article.

[PressRelease]

(TheNewswire)Kelowna, British Columbia – October 15, 2024 – Lexaria Bioscience Corp. (Nasdaq: LEXX, LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, today announced that it has entered into a definitive agreement for the purchase and sale of 1,633,987 shares of...read article.

[shawk]

Lexaria's GLP-1 Human Pilot Study #3 Begins Dosing (accesswire.com)

[shawk]

Game-Changing Oral GLP-1 Coming Soon! (youtube.com) About the 8 minute mark.

[PressRelease]

(TheNewswire)Kelowna, British Columbia – October 1, 2024 – TheNewswire – Lexaria Bioscience Corp. (Nasdaq: LEXX & LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms announces the appointment of Michael Shankman, CPA, as Chief Financial Officer (CFO) effective...read article.

[PressRelease]

(TheNewswire)First-ever DehydraTECH-processed tirzepatide from Zepbound® to be tested in a swallowed oral formatKelowna, British Columbia – September 27, 2024 – TheNewswire – Lexaria Bioscience Corp. (Nasdaq: LEXX, LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms...read article.

[whytestocks]

Breaking News: $LEXX Lexaria Bioscience Corp. (NASDAQ: LEXX) Demonstrates Continued DehydraTECH(TM)-Liraglutide Performance with Ongoing GLP-1 Diabetes Animal StudyLexaria, a global innovator in drug